Oruka Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Oruka Therapeutics, Inc. (ORKA) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $3.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-10
- Oruka Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $5.06M.
- Oruka Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$1.30M, a 156.28% decline year-over-year.
- Oruka Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $2.21M.
- Oruka Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $4.81M.
- Oruka Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $7.25M.
- Oruka Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$526.00K.
- Oruka Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$934.00K, a 314.71% decline from fiscal 2021.
- Oruka Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2021 was $435.00K, a 3.33% decline from fiscal 2020.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 2 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 5 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 8 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 11 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $3.76M 10-Q · filed 2026-08-10 | $5.96M derived: sum of 3 quarters · filed 2026-08-10 | $10.77M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$1.30M 10-Q · filed 2026-05-13 | $903.00K derived: sum of 2 quarters · filed 2026-05-13 | $5.71M derived: sum of 3 quarters · filed 2026-05-13 | $3.62M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $7.01M derived: sum of 2 quarters · filed 2026-03-12 | $4.93M derived: sum of 3 quarters · filed 2026-08-10 | $7.25M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $4.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.72M derived: sum of 2 quarters · filed 2026-08-10 | $5.04M 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | -$2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $232.00K 10-Q · filed 2026-08-10 | ||||||
| 2025-03-31 | $2.32M 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | $3.29M 10-K · filed 2026-03-12 | |||||||
| 2024-09-30 | $1.65M 10-Q · filed 2025-11-12 | |||||||
| 2024-06-30 | -$377.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $683.00K 10-Q · filed 2025-08-11 | $426.00K 10-Q · filed 2024-08-01 | -$1.00K derived: sum of 3 quarters · filed 2024-08-01 | -$609.00K derived: sum of 4 quarters · filed 2024-08-01 | |||
| 2024-03-31 | $773.00K 10-Q · filed 2025-05-14 | $803.00K 10-Q · filed 2024-04-25 | $376.00K derived: sum of 2 quarters · filed 2024-04-25 | -$232.00K derived: sum of 3 quarters · filed 2024-04-25 | $255.00K derived: sum of 4 quarters · filed 2024-08-01 | |||
| 2023-12-31 | -$427.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | -$1.03M derived: sum of 2 quarters · filed 2024-02-01 | -$548.00K derived: sum of 3 quarters · filed 2024-08-01 | -$526.00K 10-K · filed 2024-02-01 | ||||
| 2023-09-30 | -$608.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-18 | -$121.00K derived: sum of 2 quarters · filed 2024-08-01 | -$99.00K 10-Q · filed 2023-10-18 | -$506.00K derived: sum of 4 quarters · filed 2024-08-01 | ||||
| 2023-06-30 | $487.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $509.00K 10-Q · filed 2024-08-01 | $102.00K derived: sum of 3 quarters · filed 2024-08-01 | -$290.00K derived: sum of 4 quarters · filed 2024-08-01 | ||||
| 2023-03-31 | $22.00K 10-Q · filed 2024-04-25 | -$385.00K derived: sum of 2 quarters · filed 2024-04-25 | -$777.00K derived: sum of 3 quarters · filed 2024-04-25 | -$963.00K derived: sum of 4 quarters · filed 2024-04-25 | ||||
| 2022-12-31 | -$407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | -$799.00K derived: sum of 2 quarters · filed 2024-02-01 | -$985.00K derived: sum of 3 quarters · filed 2024-02-01 | -$934.00K 10-K · filed 2024-02-01 | ||||
| 2022-09-30 | -$392.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-18 | -$578.00K derived: sum of 2 quarters · filed 2023-10-18 | -$527.00K 10-Q · filed 2023-10-18 | -$1.00M derived: sum of 4 quarters · filed 2023-10-18 | ||||
| 2022-06-30 | -$186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-21 | -$135.00K 10-Q · filed 2023-07-21 | -$610.00K derived: sum of 3 quarters · filed 2023-07-21 | -$30.00K derived: sum of 4 quarters · filed 2023-07-21 | ||||
| 2022-03-31 | $51.00K 10-Q · filed 2023-04-24 | -$424.00K derived: sum of 2 quarters · filed 2023-04-24 | $156.00K derived: sum of 3 quarters · filed 2023-04-24 | $425.00K derived: sum of 4 quarters · filed 2023-04-24 | ||||
| 2021-12-31 | -$475.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $105.00K derived: sum of 2 quarters · filed 2023-02-24 | $374.00K derived: sum of 3 quarters · filed 2023-02-24 | $435.00K 10-K · filed 2023-02-24 | ||||
| 2021-09-30 | $580.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $849.00K derived: sum of 2 quarters · filed 2022-10-28 | $910.00K 10-Q · filed 2022-10-28 | $1.46M derived: sum of 4 quarters · filed 2022-10-28 | ||||
| 2021-06-30 | $269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $330.00K 10-Q · filed 2022-08-02 | $881.00K derived: sum of 3 quarters · filed 2022-08-02 | $972.00K derived: sum of 4 quarters · filed 2022-08-02 | ||||
| 2021-03-31 | $61.00K 10-Q · filed 2022-05-02 | $612.00K derived: sum of 2 quarters · filed 2022-05-02 | $703.00K derived: sum of 3 quarters · filed 2022-05-02 | $610.00K derived: sum of 4 quarters · filed 2022-05-02 | ||||
| 2020-12-31 | $551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $642.00K derived: sum of 2 quarters · filed 2022-03-14 | $549.00K derived: sum of 3 quarters · filed 2022-03-14 | $450.00K 10-K · filed 2022-03-14 | ||||
| 2020-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$2.00K derived: sum of 2 quarters · filed 2021-11-02 | -$101.00K 10-Q · filed 2021-11-02 | -$480.00K derived: sum of 4 quarters · filed 2021-11-02 | ||||
| 2020-06-30 | -$93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$192.00K 10-Q · filed 2021-08-04 | -$571.00K derived: sum of 3 quarters · filed 2021-08-04 | -$413.00K derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | -$99.00K 10-Q · filed 2021-05-11 | -$478.00K derived: sum of 2 quarters · filed 2021-05-11 | -$320.00K derived: sum of 3 quarters · filed 2021-05-11 | -$194.00K derived: sum of 4 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | -$379.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$221.00K derived: sum of 2 quarters · filed 2021-03-18 | -$95.00K derived: sum of 3 quarters · filed 2021-03-18 | -$127.00K 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $284.00K derived: sum of 2 quarters · filed 2020-11-02 | $252.00K 10-Q · filed 2020-11-02 | $189.00K derived: sum of 4 quarters · filed 2020-11-02 | ||||
| 2019-06-30 | $126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $94.00K 10-Q · filed 2020-08-05 | $31.00K derived: sum of 3 quarters · filed 2020-08-05 | $83.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | -$32.00K 10-Q · filed 2020-05-06 | -$95.00K derived: sum of 2 quarters · filed 2020-05-06 | -$43.00K derived: sum of 3 quarters · filed 2020-05-06 | -$134.00K derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$11.00K derived: sum of 2 quarters · filed 2020-02-18 | -$102.00K derived: sum of 3 quarters · filed 2020-02-18 | -$298.00K 10-K · filed 2020-02-18 | ||||
| 2018-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$39.00K derived: sum of 2 quarters · filed 2019-11-06 | -$235.00K 10-Q · filed 2019-11-06 | -$632.00K derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2018-06-30 | -$91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$287.00K 10-Q · filed 2019-08-01 | -$684.00K derived: sum of 3 quarters · filed 2019-08-01 | -$765.00K derived: sum of 4 quarters · filed 2019-08-01 | ||||
| 2018-03-31 | -$196.00K 10-Q · filed 2019-05-08 | -$593.00K derived: sum of 2 quarters · filed 2019-05-08 | -$674.00K derived: sum of 3 quarters · filed 2019-05-08 | -$530.00K derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | -$397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$478.00K derived: sum of 2 quarters · filed 2019-02-27 | -$334.00K derived: sum of 3 quarters · filed 2019-02-27 | $193.00K 10-K · filed 2019-02-27 | ||||
| 2017-09-30 | -$81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $63.00K derived: sum of 2 quarters · filed 2018-11-14 | $590.00K 10-Q · filed 2018-11-14 | $196.00K derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $671.00K 10-Q · filed 2018-08-09 | $277.00K derived: sum of 3 quarters · filed 2018-08-09 | $293.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $527.00K 10-Q · filed 2018-05-08 | $133.00K derived: sum of 2 quarters · filed 2018-05-08 | $149.00K derived: sum of 3 quarters · filed 2018-05-08 | $556.00K derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | -$394.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | -$378.00K derived: sum of 2 quarters · filed 2018-03-22 | $29.00K derived: sum of 3 quarters · filed 2018-03-22 | -$3.00K 10-K · filed 2018-03-22 | ||||
| 2016-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $423.00K derived: sum of 2 quarters · filed 2017-11-09 | $391.00K 10-Q · filed 2017-11-09 | $358.00K derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | $407.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $375.00K 10-Q · filed 2017-08-03 | $342.00K derived: sum of 3 quarters · filed 2017-08-03 | $547.00K derived: sum of 4 quarters · filed 2017-08-03 | ||||
| 2016-03-31 | -$32.00K 10-Q · filed 2017-05-15 | -$65.00K derived: sum of 2 quarters · filed 2017-05-15 | $140.00K derived: sum of 3 quarters · filed 2017-05-15 | $207.00K derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $172.00K derived: sum of 2 quarters · filed 2017-03-21 | $239.00K derived: sum of 3 quarters · filed 2017-03-21 | $196.00K 10-K · filed 2017-03-21 | ||||
| 2015-09-30 | $205.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $272.00K derived: sum of 2 quarters · filed 2016-11-14 | $229.00K 10-Q · filed 2016-11-14 | $119.00K derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $24.00K 10-Q · filed 2016-08-09 | -$86.00K derived: sum of 3 quarters · filed 2016-08-09 | -$12.00K derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-03-31 | -$43.00K 10-Q · filed 2016-05-11 | -$153.00K derived: sum of 2 quarters · filed 2016-05-11 | -$79.00K derived: sum of 3 quarters · filed 2016-05-11 | -$108.00K derived: sum of 4 quarters · filed 2016-05-11 | ||||
| 2014-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | -$36.00K derived: sum of 2 quarters · filed 2016-03-17 | -$65.00K derived: sum of 3 quarters · filed 2016-03-17 | -$182.00K 10-K · filed 2016-03-17 | ||||
| 2014-09-30 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $45.00K derived: sum of 2 quarters · filed 2015-11-12 | -$72.00K 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$146.00K 10-Q · filed 2015-08-11 | ||||||
| 2014-03-31 | -$117.00K 10-Q · filed 2015-05-12 | |||||||
| 2013-12-31 | $325.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |